학술논문

H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.
Document Type
Article
Source
Nature Genetics. Jan2013, Vol. 45 Issue 1, p34-42. 9p. 1 Diagram, 6 Graphs.
Subject
*PLURIPOTENT stem cells
*METHYLATION
*SOMATIC cells
*VITAMIN C
*BONE morphogenetic proteins
*CELLULAR signal transduction
*HISTONES
Language
ISSN
1061-4036
Abstract
The induction of pluripotent stem cells (iPSCs) by defined factors is poorly understood stepwise. Here, we show that histone H3 lysine 9 (H3K9) methylation is the primary epigenetic determinant for the intermediate pre-iPSC state, and its removal leads to fully reprogrammed iPSCs. We generated a panel of stable pre-iPSCs that exhibit pluripotent properties but do not activate the core pluripotency network, although they remain sensitive to vitamin C for conversion into iPSCs. Bone morphogenetic proteins (BMPs) were subsequently identified in serum as critical signaling molecules in arresting reprogramming at the pre-iPSC state. Mechanistically, we identified H3K9 methyltransferases as downstream targets of BMPs and showed that they function with their corresponding demethylases as the on/off switch for the pre-iPSC fate by regulating H3K9 methylation status at the core pluripotency loci. Our results not only establish pre-iPSCs as an epigenetically stable signpost along the reprogramming road map, but they also provide mechanistic insights into the epigenetic reprogramming of cell fate. [ABSTRACT FROM AUTHOR]